This Solicitation opportunity from Department Of Defense was posted on May 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
MOXIFLOXACIN HYDROC
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
Moxifloxacin Hydrochloride tablets, 400 mg in 30-count bottles, are being procured under solicitation SPE2DP-26-T-3478 by the Defense Logistics Agency for delivery to USS MOBILE (LCS-26) at FPO AP 96694. The contract specifies a total quantity of five bottles, with a unit price of $88.00 resulting in a total contract value of $440.00, and requires delivery within 20 days of award with FOB Destination terms. All packaging must meet commercial standards under ASTM D3951 for non-hazardous materials, though packaging must comply with TQ Requirement IP025 if deemed hazardous under FED-STD-313, with all DLA Master List of Technical and Quality Requirements overriding ASTM standards. Packaging and labeling must adhere strictly to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions, including proper barcoding, unit of issue marking, and preservation indicators. Each bottle must be sealed in a protective unit container, packed in robust shipping containers suitable for safe transport via common carrier at lowest cost, and palletized according to RP001 requirements. The product has a non-extendable 36-month shelf life as a TYPE I (CODE Q) item and must be stored at controlled room temperature with low humidity. The item is regulated by the FDA, and buyers must refer the bidder and manufacturer information through EBS for confirmation. Contractual fulfillment is subject to final inspection and acceptance at the destination point, with full compliance expected in all aspects of packaging, labeling, and delivery. The contract applies federal acquisition regulations including clauses on small business representation, employment equality, trafficking in persons, cybersecurity, safeguarding covered defense information, and prohibition on acquisition of certain telecommunications equipment, with payment to be processed electronically via WAWF using an invoice and receiving report. The solicitation is closed to electronic submissions via DIBBS by May 26, 2026, and includes mandatory representations regarding unique entity identifiers, socioeconomic status, and compliance with hazardous material labeling standards under OSHA and relevant federal acts.
General Info
Agency
NAICS
Place of Performance
UNIT 100472 BOX 1, FPO, AP, 96694, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
MOXIFLOXACIN HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
400 MG 30'S TABLETS PER BOTTLE. UNIT OF ISSUE "BOTTLE". STORE AT
CONTROLLED ROOM TEMPERATURE; AVOID HIGH HUMIDITY .. LABELING AND MARKING
MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY
2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 BT = 30 EA RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-3478
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RISING PHARMA HOLDINGS, INC. 8FG82 P/N NDC57237-0156-30 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00093-7387-56
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016833667 0001 BT 5.000
NSN/MATERIAL:6505015034772
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R20170
USS MOBILE (LCS 26) BLUE
AIR DEPARTMENT (HSM49 DET 2)
UNIT 100472 BOX 1
FPO AP 96694
US
SPE2DP-26-T-3478
SECTION B
PR: 7016833667 PRLI: 0001 CONT’D
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R20170
USS MOBILE (LCS-26)
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
M/F: (TCN) R201706135M194
RDD: 777
PROJ: ZJ7 TP 2
SUPP ADD: YNMH01 SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 06
DIC: A4A DIST: 9B ADV: 2A FC: N7
Need Ship Date:00/00/0000 Original Required Delivery Date:05/21/2026
SPE2DP-26-T-3478 NSN/Part Number: 6505-01-503-4772 Quantity: 5 BT Purchase Request: 7016833667QTY: 5 Delivery: 20 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS